Yu Peng - Net Worth and Insider Trading
Yu Peng Net Worth
The estimated net worth of Yu Peng is at least $12 Million dollars as of 2025-04-14. Yu Peng is the senior management of Henan Lingrui Pharmaceutical Co Ltd and owns about 550,000 shares of Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) stock worth over $12 Million. Details can be seen in Yu Peng's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Yu Peng has not made any transactions after 2025-01-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Yu Peng
Yu Peng Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Yu Peng owns 1 companies in total, including Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) .
Click here to see the complete history of Yu Peng’s form 4 insider trades.
Insider Ownership Summary of Yu Peng
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600285 | Henan Lingrui Pharmaceutical Co Ltd | 2025-01-09 | Director |
Yu Peng Latest Holdings Summary
Yu Peng currently owns a total of 1 stock. Yu Peng owns 550,000 shares of Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) as of January 9, 2025, with a value of $12 Million.
Latest Holdings of Yu Peng
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600285 | Henan Lingrui Pharmaceutical Co Ltd | 2025-01-09 | 550,000 | 22.37 | 12,303,500 |
Holding Weightings of Yu Peng
Yu Peng Form 4 Trading Tracker
According to the SEC Form 4 filings, Yu Peng has made a total of 2 transactions in Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Henan Lingrui Pharmaceutical Co Ltd is the sale of 150,000 shares on January 9, 2025, which brought Yu Peng around $2 Million.
Insider Trading History of Yu Peng
- 1
Yu Peng Trading Performance
GuruFocus tracks the stock performance after each of Yu Peng's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yu Peng is -3.05%. GuruFocus also compares Yu Peng's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yu Peng within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Yu Peng's insider trading performs compared to the benchmark.
Performance of Yu Peng
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.11 | | | | | |
| Relative Return to S&P 500(%) | -10.17 | | | | | |
Yu Peng Ownership Network
Ownership Network List of Yu Peng
Ownership Network Relation of Yu Peng
Yu Peng Owned Company Details
What does Henan Lingrui Pharmaceutical Co Ltd do?
Who are the key executives at Henan Lingrui Pharmaceutical Co Ltd?
Yu Peng is the Director of Henan Lingrui Pharmaceutical Co Ltd. Other key executives at Henan Lingrui Pharmaceutical Co Ltd include senior management Ye Qiang , Directors & senior managers Chen Yan , and senior management Wu Hui Bin .
Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) Insider Trades Summary
Over the past 18 months, Yu Peng made 1 insider transaction in Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) with a net sale of 0. Other recent insider transactions involving Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) include a net sale of 138,500 shares made by Wu Xi Zhen , a net sale of 47,600 shares made by Li Jin , and a net sale of 0 shares made by Li Lei .
In summary, during the past 3 months, insiders sold 0 shares of Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 186,100 shares of Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) were sold and 0 shares were bought by its insiders, resulting in a net sale of 186,100 shares.
Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285)'s detailed insider trading history can be found in Insider Trading Tracker table.
Henan Lingrui Pharmaceutical Co Ltd Insider Transactions
Yu Peng Mailing Address
Above is the net worth, insider trading, and ownership report for Yu Peng. Currently GuruFocus does not have mailing address information for Yu Peng.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
